logo
  

U.S. Purchases Addl 200 Mln Doses Of Moderna COVID-19 Vaccine

The U.S. government has purchased an additional 200 million doses of Moderna's COVID-19 vaccine, including the option to purchase other COVID-19 vaccine candidates from the company's pipeline, Moderna said in a statement.

The purchase brings the U.S. government's confirmed order commitment to 500 million doses including 110 million doses expected to be delivered in the fourth quarter of 2021 and 90 million expected to be delivered in the first quarter of 2022.

As of June 14, Moderna has supplied 217 million released doses of the vaccine to the U.S. government.

On December 18, 2020, the U.S. FDA authorized the emergency use of the Moderna COVID-19 Vaccine in individuals 18 years of age or older. Moderna has received emergency or other conditional, interim or provisional authorization for use of its COVID-19 vaccine in adults from health agencies in Canada, Israel, the European Union, the United Kingdom, Switzerland, Singapore, Qatar, Taiwan, the Philippines, Thailand, Brunei, Paraguay, Japan, South Korea, Botswana and an Emergency Use Listing from the World Health Organization (WHO).

Moderna has filed for emergency or other conditional, interim or provisional authorization for use of its COVID-19 vaccine in adolescents with health agencies in the European Union, Canada, the U.S., Switzerland and Japan.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT